Finance

Lists
603567:SHA
Heilongjiang ZBD Pharmaceutical Co Ltd
5,04 CNY
-1,95%
(-0,100) 1D
16 ოქტ, 15:00:02 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603567...
Open
5,17 CNY
High
5,30 CNY
Low
5,00 CNY
Mkt. cap
4,94 მლრდ.
Avg. vol.
23,25 მლნ.
Volume
25,29 მლნ.
52-wk high
12,14 CNY
52-wk low
4,21 CNY
EPS
-1,53 CNY
Shares outstanding
849,16 მლნ.
No. of employees
2 ათ.
Open
5,17 CNY
High
5,30 CNY
Low
5,00 CNY
Mkt. cap
4,94 მლრდ.
Avg. vol.
23,25 მლნ.
Volume
25,29 მლნ.
52-wk high
12,14 CNY
52-wk low
4,21 CNY
EPS
-1,53 CNY
Shares outstanding
849,16 მლნ.
No. of employees
2 ათ.
News stories
From web sources and news partners
Law360
Law360
·
37 წუთის წინ
Nasdaq Sued Over Delisting Of Social Media Co.
MarketBeat
MarketBeat
·
11 წუთის წინ
Billiontoone (NASDAQ:BLLN) CEO Sells $313,016.22 in Stock
Moomoo
Moomoo
·
15 წუთის წინ
28.2 Close
Seeking Alpha
Seeking Alpha
·
37 წუთის წინ
S&P 500 Snapshot: Stocks Slide Nearly 2% For The Week
About Heilongjiang ZBD Pharmaceutical Co Ltd
CEO-
Employees1,96 ათ.
Founded28 ოქტ. 1996
Headquarters-
SectorPharmaceutical industry
Websitezbdzy.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
204,78 მლნ.
-120,85 მლნ.
181,56 მლნ.
113,79 მლნ.
Cost of goods sold
206,91 მლნ.
600,55 მლნ.
180,99 მლნ.
54,52 მლნ.
Cost of revenue
206,91 მლნ.
600,55 მლნ.
180,99 მლნ.
54,52 მლნ.
Research and development expenses
8,75 მლნ.
26,82 მლნ.
8,64 მლნ.
-3,48 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
99,80 მლნ.
43,54 მლნ.
71,31 მლნ.
74,02 მლნ.
Operating expense
137,83 მლნ.
225,64 მლნ.
209,39 მლნ.
120,96 მლნ.
Total operating expenses
344,75 მლნ.
826,18 მლნ.
390,38 მლნ.
175,48 მლნ.
Operating income
-139,97 მლნ.
-947,03 მლნ.
-208,82 მლნ.
-61,69 მლნ.
Other non operating income
12,87 მლნ.
-374,29 მლნ.
-102,60 ათ.
10,46 მლნ.
EBT including unusual items
-350,54 მლნ.
-1,16 მლრდ.
-226,54 მლნ.
-100,48 მლნ.
EBT excluding unusual items
-168,80 მლნ.
-1,31 მლრდ.
-241,63 მლნ.
-74,50 მლნ.
Income tax expense
-55,10 მლნ.
-168,17 მლნ.
-45,60 მლნ.
-11,32 მლნ.
Effective tax rate
15,72%
14,47%
20,13%
11,27%
Other operating expenses
-34,39 მლნ.
40,92 მლნ.
7,96 მლნ.
8,89 მლნ.
Net income
-294,81 მლნ.
-993,43 მლნ.
-179,95 მლნ.
-91,03 მლნ.
Net profit margin
-143,97%
822,03%
-99,11%
-79,99%
Earnings per share
-
-
-
-
Interest and investment income
137,59 ათ.
31,21 მლნ.
104,31 ათ.
88,56 ათ.
Interest expense
-41,82 მლნ.
-24,43 მლნ.
-30,57 მლნ.
-25,61 მლნ.
Net interest expenses
-41,69 მლნ.
6,78 მლნ.
-30,46 მლნ.
-25,52 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-101,46 მლნ.
-905,32 მლნ.
-167,10 მლნ.
-20,49 მლნ.
Gain or loss from assets sale
-
612,90 ათ.
-
-
AI content may include mistakes. Learn more
Google აპები